Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?

Ahmet Dirican, Betül Bolat Küçükzeybek, Ahmet Alacacıoğlu, +11

International Journal of Clinical Oncology

Lymphoid NeoplasiaBreast OncologyMedicineImmunologyPathology +5

Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs

Lütfiye Demir, Seyran Yiğit, Hülya Ellıdokuz, +9

Clinical & Experimental Metastasis

Prognostic FactorsAdvanced Breast CancerBreast OncologyMedicinePathology +5

Depression, Anxiety and Sexual Satisfaction in Breast Cancer Patients and their Partners-Izmir Oncology Group Study

Ahmet Alacacıoğlu, Eda Ülger, Umut Varol, +11

Asian Pacific Journal of Cancer Prevention

The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer

Ahmet Dirican, Neşe Ekinci, Murat Akyol, +9

Cancer Biomarkers

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, +19

Breast Cancer

Breast OncologyCapecitabine Combination TherapyMedicineBrain MetastasisClinical Outcomes +5

Prognostic and Predictive Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma: Second Line Sunitinib Treatment Following IFN-alpha

Ahmet Dirican, Yüksel Küçükzeybek, Çiğdem Erten, +8

Asian Pacific Journal of Cancer Prevention

Metastases of renal cell carcinoma to the larynx and thyroid: Two case reports on metastasis developing years after nephrectomy

Lütfiye Demir, Çiğdem Erten, Alper Can, +7

Canadian Urological Association Journal

UrologySurgical OncologyMalignant DiseaseGenitourinary CancerMedicine +11

Prognostic Evaluation of Breast Cancer Patients with Evident Bone Marrow Metastasis

Lütfiye Demir, Murat Akyol, Sadi Bener, +9

The Breast Journal

Hematological MalignancyPrognostic EvaluationBreast OncologyBreast Cancer PatientsMedicine +10

Cisplatin Plus Gemcitabine for Treatment of Breast Cancer Patients with Brain Metastases: a Preferential Option for Triple Negative Patients?

Çiğdem Erten, Lütfiye Demir, Ahmet Alacacıoğlu, +6

Asian Pacific Journal of Cancer Prevention

Treatment of Metastatic Colorectal Cancer With or Without Bevacizumab: Can the Neutrophil/Lymphocyte Ratio Predict the Efficiency of Bevacizumab?

Ahmet Dirican, Umut Varol, Yüksel Küçükzeybek, +9

Asian Pacific Journal of Cancer Prevention